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nger, Depression, and
nxiety in Cardiac Patients
he Complexity of Individual
ifferences in Psychological Risk*
ohan Denollet, PHD, Susanne S. Pedersen, PHD
ilburg, the Netherlands
couple of years ago, a large meta-analytic review con-
luded that depression can be considered a prognostic factor
n coronary heart disease (CHD) (1). Depression has also
een associated with increased mortality in heart failure (2).
owever, although a recent advisory from a number of
ouncils of the American Heart Association recommends
outine screening for depression of CHD patients in clinical
ractice (3), a systematic review published 1 month later did
ot find evidence for or against this recommendation (4). In
his issue of the Journal, Chida and Steptoe (5) report on a
eta-analysis of prospective studies on the association
etween another psychological factor, anger/hostility, and
he risk of CHD.
See page 936
nger, hostility, and CHD. In their meta-analysis of 25
rospective studies on the incidence of CHD and 20 studies
f patients with established CHD, the authors found that
nger/hostility was associated with a 20% increased risk of
oth incident CHD in initially healthy individuals and poor
rognosis in CHD patients (5). On the basis of these
ndings, they conclude that anger/hostility is associated
ith CHD outcomes and that intervention should focus on
he psychological management of anger/hostility in the
revention and treatment of CHD.
The authors are to be commended for having conducted
his methodologically well-performed meta-analysis sup-
orting the role of psychological factors in the onset and
rognosis of CHD. Their study provides an important
ontribution to the cardiovascular literature, because traits
uch as anger/hostility are less likely to arise as a conse-
uence of somatic disease. Although depression might be
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.o
From the CoRPS-Center of Research on Psychology in Somatic diseases, Tilburg
niversity, Tilburg, the Netherlands.onfounded by left ventricular dysfunction in patients with
HD (1), anger/hostility measures do not include somatic
ymptoms. Although the risk incurred by anger/hostility of
0% is relatively small, when placed in the context of the 11%
isk associated with von Willebrand factor as a predictor of
ncident CHD in the Reykjavik study (6), this effect attributed
o a psychological factor seems notable.
It could be argued, however, that anger and hostility do
ot comprise 1 behavioral construct, as was also posited by
he authors. Hence, merging of the 2 factors into 1
onstruct obscures any differential cardiotoxic effects that
oth psychological factors might have. This might also have
mplications for interventions, as seen in the current debate
n depression as a potential cardiovascular risk factor (7).
esearchers focusing on the role of depression are increas-
ngly recognizing that depression in cardiac patients does
ot involve a homogeneous diagnostic category but might
omprise distinctly different subtypes and is qualitatively
ifferent from depression seen in psychiatric patients. Some
anifestations of depression might even reflect the severity
f cardiac disease (1). In other words, pinpointing the most
ardiotoxic depressive symptoms and whether it is incident,
ecurrent, or chronic depression that incurs an increased risk
ight change how we design intervention trials targeting
epression in CHD (7).
he complex network of psychological factors. Chida
nd Steptoe (5) focused on 1 psychological factor, but in real
ife, psychological factors might cluster together within
ndividuals to substantially increase the risk of clinical events
8). Arguably, it is difficult to conduct a meta-analysis that
atches this complexity. However, different psychological
actors might promote CHD (9–13). Although anxiety is
ommon among cardiovascular patients and increases the
isk of cardiac events if untreated (9–11), only 1 of 3 anxious
atients is asked about such symptoms. Recently, Ladwig et
l. (12) showed that treatment with an implantable cardio-
erter defibrillator might induce post-traumatic stress and
hat this stress independently predicts a greater risk for
ortality. In a state-of-the-art paper previously published in
he Journal, Dimsdale (13) discusses how psychological
tress might lead to pathophysiological changes that ulti-
ately become manifest as hard medical events, such as
ortality and morbidity. Hence, it is important to take a
oment to acknowledge the existence of this complexity
nd what the consequences might be if we do not.
Clinical research on the modulation of inflammation in
eart failure might serve as an illustrative analogy. Despite
vidence that increased levels of the pro-inflammatory
ytokine tumor necrosis factor- and its receptors predict
oor prognosis in heart failure, clinical trials targeting this
pecific cytokine produced disappointing findings. How-
ver, as shown in the ACCLAIM (Advanced Chronic heart
ailure CLinical Assessment of Immune Modulation ther-
py) trial, focusing on cytokine networks rather than specific
r single cytokines might be a more successful approach,
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Psychological Factors and CHD Risk March 17, 2009:947–9ecause this broad immunomodulation therapy led to im-
roved survival (14).
ppreciating individual differences in risk. As an anal-
gy, the role of psychological factors in the onset and
rogression of CHD should also be studied in concert rather
han using an individual risk factor approach (8). The
nsuing question is then: how can physicians deal with the
omplexity of improving patient outcomes by placing all of
hese psychological factors in the forefront of clinical car-
iology practice?
One of the answers might be to acknowledge that the
sychological risk is not uniform across all patients and that
sychological factors might cluster together within individ-
als (8). As Dimsdale notes, “vulnerability and resilience
actors play a role in amplifying or dampening” the effects of
sychological factors on the heart (13), with these factors
elonging to the realm of personality (11,15). A broad,
table disposition to experience psychological distress has
een associated with poor outcome after percutaneous
oronary intervention in the RESEARCH (Rapamycin-
luting Stent Evaluated at Rotterdam Cardiology Hospital)
egistry (15). This broad disposition toward psychological
istress might also partly explain individual differences in
hysiological stress-reactivity, such as an increased level of
he stress-hormone cortisol in patients with CHD (16).
urrently, these individual differences are largely ignored in
linical research and practice, but they could be assessed
ith brief and standardized self-report measures and would
o away with a single risk factor approach.
roadening the focus of intervention. Needless to say,
he challenges we face are numerous. A major challenge is to
evelop more effective treatments for cardiac patients at risk
f poor prognosis and quality of life due to their psycho-
ogical profile. Interventions might need to be more broadly
ocused, targeting the various emotional and social difficul-
ies that patients face (17), hopefully with beneficial results
imilar to those of the ACCLAIM trial (14). It might be
mportant to tailor interventions to the individual patient to
nd out what works for whom. Comprehensive cardiac
ehabilitation offers several opportunities in this context, but
ome patients with psychological comorbidity might need
ore intensive treatment and should be referred to special-
zed healthcare professionals.
In future trials, it is important to pay particular
ttention to nonresponders to intervention, because these
atients have been shown to be at a higher risk of late
ortality compared with responders (18). Although as
et we might not have the answer as to how to moderate
he psychological risk of patients in terms of improved
urvival, let us not forget that psychological factors also
erve as barriers for lifestyle changes (such as smoking
essation), treatment adherence, and participation in
utpatient rehabilitation programs, and have an adverse
nfluence on health status. Hence, survival should be the
nly end point neither for research purposes nor in
1linical practice when seeking to moderate the impact of
he psychological factor.
To conclude, the meta-analysis by Chida and Steptoe (5)
arries with it several important messages, including that:
) psychological factors do matter in CHD; 2) pursuing
ulnerability and resilience factors might be particularly
orthwhile, because they might be less prone to confound-
ng by disease severity; and 3) although we might be far
rom having all of the answers, the risk associated with
sychological factors is similar to that of other clinical risk
ndicators.
eprint requests and correspondence: Dr. Johan Denollet,
oRPS, Department of Medical Psychology, Tilburg University,
.O. Box 90153, 5000 LE Tilburg, the Netherlands. E-mail:
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